Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-11-22

Clinical Trial Update: Randomized AmnioFix Study During Radical Prostatectomy [Phase 2]

View source ↗

Summary

A randomized Phase 2 trial evaluating AmnioFix during radical prostatectomy for prostate cancer has been withdrawn. The sponsor is MD Anderson Cancer Center, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AmnioFix

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: WITHDRAWN